Associate Director, Clinical Operations Compliance & Training

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Requirements

• Lead and/or support development and implementation of GCP systems and inspection readiness
• Lead and/or support the development and continuous improvement of Clinical Policies/ SOPs/ WIs/ Templates/etc.
• SME for Clinical Operations GCP guidance, best industry practices, SOPs, and audit responses
• Contribute to the development and management of business and compliance metrics to assess and continuously improve RevMed oversight and inspection readiness throughout the clinical trial lifecycle
• Support Clinical Operations Inspection Readiness activities with clinical study teams; key participation in Mock/Regulatory Authority inspections
• Contribute to the development and execution of Clinical Operations training programs to deliver RevMed standards, GCP, and regulatory requirements
• Partner cross-functionally and with QA on quality initiatives, continuous improvement of GCP systems, and internal audits
• Line management responsibilities including hiring, performance management, career development, and mentorship

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities